Browse by Title

Type here to filter the list

R
Racial Disparities in Paxlovid Use Treating for High Risk COVID-19 Patients – A Large Population Based Study Using US Claim Data

Xiaofeng Zhou, PhD – Pfizer Inc ### 1062976###Presenting Author###Sr. Director###Pfizer Inc###
Presenting Author: Xiaofeng Zhou, PhD – Pfizer Inc
### @@@ Ling Li – Kite ### 1358441###Co-Author###associate director RWE###Kite###
Co-Author: Ling Li – Kite
### @@@ Scott P. Kelly, PhD – Pfizer Inc, Global Medical Epidemiology, New York, NY ### 1358440###Co-Author###Senior Director, Global Medical Epidemiology ###Pfizer Inc, Global Medical Epidemiology, New York, NY###
Co-Author: Scott P. Kelly, PhD – Pfizer Inc, Global Medical Epidemiology, New York, NY
### @@@ Heidi Leister-Tebbe – Pfizer Inc ### 1991522###Co-Author######Pfizer Inc###
Co-Author: Heidi Leister-Tebbe – Pfizer Inc
### @@@ Steven G. Terra – Pfizer Inc ### 1991523###Co-Author######Pfizer Inc###
Co-Author: Steven G. Terra – Pfizer Inc
### @@@ Rongjun Shen – Pfizer Inc ### 1358103###Co-Author######Pfizer Inc###
Co-Author: Rongjun Shen – Pfizer Inc
### @@@ Mark Cullen, MD – Independent Researcher ### 1991426###Co-Author######Independent Researcher###
Co-Author: Mark Cullen, MD – Independent Researcher
### @@@ Michael Gaffney, PhD. – Pfizer Inc ### 1991524###Co-Author###Vice President, Statistics###Pfizer Inc###
Co-Author: Michael Gaffney, PhD. – Pfizer Inc
### @@@ Leo J. Russo, PhD – Pfizer ### 1658914###Co-Author###VP, Global Medical Epidemiology###Pfizer###
Co-Author: Leo J. Russo, PhD – Pfizer
###
Ready or Not, Here Come Estimands! The Emerging Attention to Causal Estimands in Real-World Evidence Studies

Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions ### 1062596###Lead Speaker###Director, Epidemiology###RTI Health Solutions###
Lead Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
### @@@ Costel Chirila, PhD – RTI Health Solutions ### 1991622###Speaker###Director of Biostatistics###RTI Health Solutions###
Speaker: Costel Chirila, PhD – RTI Health Solutions
### @@@ Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health ### 1360646###Speaker######CAUSALab, Harvard T.H. Chan School of Public Health###
Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health
### @@@ Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency ### 1062632###Speaker###Senior Clinical Epidemiologist###European Medicines Agency###
Speaker: Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency
### @@@ Jason A. Roy, PhD – Rutgers University School of Public Health ### 1360415###Speaker###Professor of Biostatistics###Rutgers University School of Public Health###
Speaker: Jason A. Roy, PhD – Rutgers University School of Public Health
### @@@ Paul Kluetz – US Food and Drug Administration ### 1993681###Speaker######US Food and Drug Administration###
Speaker: Paul Kluetz – US Food and Drug Administration
###
Real World Evidence BRIDGE (BRing Intelligence about Data to Generation of Evidence): a method to connect protocol with programming practice

Albert Cid-Royo, PhDs – UMC Utrecht ### 1991258###Presenting Author###PhD Student###UMC Utrecht###
Presenting Author: Albert Cid-Royo, PhDs – UMC Utrecht
### @@@ Roel JH Elbers – Department of Datascience & Biostatistics, University Medical Center Utrecht ### 1657471###Co-Author######Department of Datascience & Biostatistics, University Medical Center Utrecht###
Co-Author: Roel JH Elbers – Department of Datascience & Biostatistics, University Medical Center Utrecht
### @@@ Ema Alsina – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1655797###Co-Author######Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###
Co-Author: Ema Alsina – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Vjola Hoxhaj, PharmD, MSc, PhD Candidate – Department of Data Science and Biostatistics, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1991500###Co-Author###PhD Candidate###Department of Data Science and Biostatistics, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###
Co-Author: Vjola Hoxhaj, PharmD, MSc, PhD Candidate – Department of Data Science and Biostatistics, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Contanza L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991498###Co-Author###Assistant Professor###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###
Co-Author: Contanza L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### @@@ Fariba Ahmadizar, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1658676###Co-Author###Assistant Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###
Co-Author: Fariba Ahmadizar, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht ### 1655741###Co-Author###Postdoctoral researcher###Julius Global Health, University Medical Center Utrecht###
Co-Author: Carlos E. Durán, MD, PhD – Julius Global Health, University Medical Center Utrecht
### @@@ Daniel Weibel, PhD – University Medical Center Utrecht ### 1360562###Co-Author###Assistant Professor###University Medical Center Utrecht###
Co-Author: Daniel Weibel, PhD – University Medical Center Utrecht
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###
Co-Author: Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
### @@@ Tiago Andres Vaz, PhD – Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991499###Co-Author###Scientific Programming Coordinator###Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands###
Co-Author: Tiago Andres Vaz, PhD – Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands
###
Real-World Data to Evaluate Severe Acute Liver Injury After Outpatient Initiation of Potentially Hepatotoxic Medications: A Series of Nationwide Cohort Studies

Jessie Torgersen, MD, MHS, MSCE – Perelman School of Medicine at the University of Pennsylvania ### 1991579###Co-Author######Perelman School of Medicine at the University of Pennsylvania###
Co-Author: Jessie Torgersen, MD, MHS, MSCE – Perelman School of Medicine at the University of Pennsylvania
### @@@ Alyssa K. Mezochow, MD – Perelman School of Medicine at the University of Pennsylvania ### 1991580###Co-Author######Perelman School of Medicine at the University of Pennsylvania###
Co-Author: Alyssa K. Mezochow, MD – Perelman School of Medicine at the University of Pennsylvania
### @@@ Craig W. Newcomb, MS – Perelman School of Medicine at the University of Pennsylvania ### 1991581###Co-Author######Perelman School of Medicine at the University of Pennsylvania###
Co-Author: Craig W. Newcomb, MS – Perelman School of Medicine at the University of Pennsylvania
### @@@ Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania ### 1655454###Co-Author######Perelman School of Medicine at the University of Pennsylvania###
Co-Author: Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania
### @@@ Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine ### 1359957###Co-Author###Professor of Epidemiology###University of Pennsylvania Perelman School of Medicine###
Co-Author: Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine
### @@@ Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine ### 1062599###Co-Author###Assistant Professor###London School of Hygiene & Tropical Medicine###
Co-Author: Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine
### @@@ Lesley S. Park, PhD, MPH – Stanford University School of Medicine ### 1991582###Co-Author######Stanford University School of Medicine###
Co-Author: Lesley S. Park, PhD, MPH – Stanford University School of Medicine
### @@@ Janet P. Tate, ScD – VA Connecticut Healthcare System ### 1359969###Co-Author###Associate Professor###VA Connecticut Healthcare System###
Co-Author: Janet P. Tate, ScD – VA Connecticut Healthcare System
### @@@ Norbert Bräu, MD – James J. Peters VA Medical Center ### 1991583###Co-Author######James J. Peters VA Medical Center###
Co-Author: Norbert Bräu, MD – James J. Peters VA Medical Center
### @@@ Debika Bhattacharya, MD – VA Greater Los Angeles Healthcare System ### 1991584###Co-Author######VA Greater Los Angeles Healthcare System###
Co-Author: Debika Bhattacharya, MD – VA Greater Los Angeles Healthcare System
### @@@ Joseph K. Lim, MD – Yale University School of Medicine ### 1991585###Co-Author######Yale University School of Medicine###
Co-Author: Joseph K. Lim, MD – Yale University School of Medicine
### @@@ Jason A. Roy, PhD – Rutgers University School of Public Health ### 1360415###Co-Author###Professor of Biostatistics###Rutgers University School of Public Health###
Co-Author: Jason A. Roy, PhD – Rutgers University School of Public Health
### @@@ Tamar H. Taddei, MD – VA Connecticut Healthcare System ### 1991586###Co-Author######VA Connecticut Healthcare System###
Co-Author: Tamar H. Taddei, MD – VA Connecticut Healthcare System
### @@@ Amy C. Justice, MD, PhD – VA Connecticut Healthcare System ### 1360015###Co-Author######VA Connecticut Healthcare System###
Co-Author: Amy C. Justice, MD, PhD – VA Connecticut Healthcare System
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Presenting Author###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###
Presenting Author: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his
Real-World Evidence (RWE) Generation for Rare Disease Drug Development and Orphan Drug Approvals

Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA ### 1063298###Lead Speaker###Category Lead, Safety Evidence for Regulators###IQVIA###
Lead Speaker: Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Laura Hester, PhD – Janssen R&D, LLC ### 1063349###Speaker###Director###Janssen R&D, LLC###
Speaker: Laura Hester, PhD – Janssen R&D, LLC
### @@@ Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions ### 1062596###Speaker###Director, Epidemiology###RTI Health Solutions###
Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
### @@@ Jie Li, PhD – US Food and Drug Administration ### 1062564###Speaker###Associate Director for RWE at Office of Surveillance and Epidemiology, CDER###US Food and Drug Administration###
Speaker: Jie Li, PhD – US Food and Drug Administration
###
Regional deprivation and stocking of Meningococcal vaccines in the United States: Does location matter?

Christopher G. Prener, PhD – Pfizer, Inc ### 1991415###Presenting Author###Director, Vaccines RWE Biocurator Scientist###Pfizer, Inc###
Presenting Author: Christopher G. Prener, PhD – Pfizer, Inc
### @@@ Eva Jodar – Pfizer, S.L.U. ### 1991416###Co-Author######Pfizer, S.L.U.###
Co-Author: Eva Jodar – Pfizer, S.L.U.
### @@@ Jessica Presa, MD – Pfizer, Inc ### 1991417###Co-Author###Medical lead###Pfizer, Inc###
Co-Author: Jessica Presa, MD – Pfizer, Inc
### @@@ Sarah Willis, PhD – Pfizer, Inc ### 1991419###Co-Author######Pfizer, Inc###
Co-Author: Sarah Willis, PhD – Pfizer, Inc
### @@@ Katharina Schley – Pfizer Pharma GmbH ### 1991420###Co-Author######Pfizer Pharma GmbH###
Co-Author: Katharina Schley – Pfizer Pharma GmbH
###
Regulatory and health technology assessment of cell and gene therapies in Europe: convergence or divergence?

Mark Hoogendoorn, BSc – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1991696###Co-Author######Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Co-Author: Mark Hoogendoorn, BSc – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Babs Fabriek, PhD – Dutch Medicines Evaluation Board ### 1991695###Co-Author######Dutch Medicines Evaluation Board###
Co-Author: Babs Fabriek, PhD – Dutch Medicines Evaluation Board
### @@@ Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1063247###Presenting Author###Assistant Professor Clinical Therapeutics###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Presenting Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### he/him/his
Regulatory Pharmacoepidemiology

Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers) – FDA/CDRH/ Office of Clinical Evidence and Analysis ### 1360585###Lead Speaker###Associate Director, ###FDA/CDRH/ Office of Clinical Evidence and Analysis ###
Lead Speaker: Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers) – FDA/CDRH/ Office of Clinical Evidence and Analysis
### she/her/hers @@@ Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency ### 1647043###Speaker###Head of Epidemiology###Medicines and Healthcare products Regulatory Agency###
Speaker: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency
###
Reporting Adverse Events Following Immunization in Ghana - Health Care Workers Experiences

Nana A. Ansah, MBChB,MSc – Navrongo Health Research Centre ### 1991364###Presenting Author###Head ,Clinical Science Department###Navrongo Health Research Centre###
Presenting Author: Nana A. Ansah, MBChB,MSc – Navrongo Health Research Centre
### @@@ Daniel Weibel, PhD – University Medical Center Utrecht ### 1360562###Co-Author###Assistant Professor###University Medical Center Utrecht###
Co-Author: Daniel Weibel, PhD – University Medical Center Utrecht
### @@@ Samuel T. Oladokun – Navrongo Health Research Centre ### 1991365###Co-Author######Navrongo Health Research Centre###
Co-Author: Samuel T. Oladokun – Navrongo Health Research Centre
### @@@ Enyonam Duah – NAVRONGO HEALTH RESEARCH CENTRE ### 1991366###Co-Author######NAVRONGO HEALTH RESEARCH CENTRE###
Co-Author: Enyonam Duah – NAVRONGO HEALTH RESEARCH CENTRE
### @@@ Patrick Ansah, MD – Navrongo Health Research Centre ### 1991367###Co-Author######Navrongo Health Research Centre###
Co-Author: Patrick Ansah, MD – Navrongo Health Research Centre
### @@@ Abraham R. Oduro, MD,PhD – Research and Development Division,Ghana Health Service ### 1991368###Co-Author###Director###Research and Development Division,Ghana Health Service###
Co-Author: Abraham R. Oduro, MD,PhD – Research and Development Division,Ghana Health Service
### @@@ Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands###
Co-Author: Miriam C. Sturkenboom, PhD – Department of Biostatistics and Research support, Julius Center for Health sciences and Primary care, University Medical Center Utrecht, the Netherlands
###
Rethinking survey samples in patient preference studies: a first-degree relative sample versus a general public proxy sample in rheumatoid arthritis prevention

Rachael DiSantostefano (she/her/hers) – Janssen Research & Development ### 1991115###Presenting Author###Senior Director, Epidemiology###Janssen Research & Development###
Presenting Author: Rachael DiSantostefano (she/her/hers) – Janssen Research & Development
### she/her/hers @@@ Gwenda Simons, MA, PhD – Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. ### 1360048###Co-Author###Research Fellow###Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.###
Co-Author: Gwenda Simons, MA, PhD – Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
### @@@ Matthias Englbrecht, PhD – Freelance Data Scientist ### 1991116###Co-Author######Freelance Data Scientist###
Co-Author: Matthias Englbrecht, PhD – Freelance Data Scientist
### @@@ Jennifer Humphreys – University of Manchester ### 1991117###Co-Author######University of Manchester###
Co-Author: Jennifer Humphreys – University of Manchester
### @@@ Ian Bruce – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK ### 1359376###Co-Author######Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK###
Co-Author: Ian Bruce – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
### @@@ Karin Schölin Bywall, PhD – School of Health, Care and Social Welfare, Division of Health and Welfare Technology, Mälardalen University, Västerås, Sweden ### 1991118###Co-Author######School of Health, Care and Social Welfare, Division of Health and Welfare Technology, Mälardalen University, Västerås, Sweden###
Co-Author: Karin Schölin Bywall, PhD – School of Health, Care and Social Welfare, Division of Health and Welfare Technology, Mälardalen University, Västerås, Sweden
### @@@ Christine Radawski – Eli Lilly and Company ### 1360050###Co-Author######Eli Lilly and Company###
Co-Author: Christine Radawski – Eli Lilly and Company
### @@@ Karim Raza – University of Birmingham, UK ### 1360051###Co-Author######University of Birmingham, UK###
Co-Author: Karim Raza – University of Birmingham, UK
### @@@ Marie Falahee, BSc PhD – University of Birmingham ### 1360047###Co-Author###Lecturer in Behavioural Rheumatology###University of Birmingham###
Co-Author: Marie Falahee, BSc PhD – University of Birmingham
### @@@ Jorien Veldwijk – Erasmus School of Health Policy & Management, Erasmus University Rotterdam ### 1360052###Co-Author######Erasmus School of Health Policy & Management, Erasmus University Rotterdam###
Co-Author: Jorien Veldwijk – Erasmus School of Health Policy & Management, Erasmus University Rotterdam
###
Risk Minimization and Communication: Science-Based Approaches and Case Studies for Designing and Evaluating Effective Interventions for the Safe Use of Medicinal Products

Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency ### 1061402###Lead Speaker###Dr.###European Medicines Agency###
Lead Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency
### @@@ Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc ### 1088147###Lead Speaker###Senior DIrector###Evidera, Inc###
Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
### @@@ Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board ### 1659255###Speaker###Professor of drug regulatory science###Dutch Medicines Evaluation Board###
Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board
### @@@ Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago ### 1046822###Speaker###Dean and Professor, Parkinson School of Health Sciences and Public Health###Loyola University Chicago###
Speaker: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago
### @@@ Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 1084118###Speaker###Manager###Janssen Research & Development, Johnson & Johnson###
Speaker: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Rania Mouchantaf, PhD (she/her/hers) – Health Canada ### 2016534###Speaker###A/Executive Director###Health Canada###
Speaker: Rania Mouchantaf, PhD (she/her/hers) – Health Canada
### she/her/hers @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###
Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
###
Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A Post-Authorization Safety Study

Soulmaz Fazeli Farsani, PharmD, Msc, PhD – Boehringer Ingelheim International GmbH ### 1655587###Presenting Author###Global Real World Evidence Process/Capability Owner###Boehringer Ingelheim International GmbH###
Presenting Author: Soulmaz Fazeli Farsani, PharmD, Msc, PhD – Boehringer Ingelheim International GmbH
### @@@ kristy Iglay – CERobs Consulting, LLC ### 1991175###Co-Author######CERobs Consulting, LLC###
Co-Author: kristy Iglay – CERobs Consulting, LLC
### @@@ Ling Zhang – Boehringer Ingelheim ### 1991176###Co-Author######Boehringer Ingelheim###
Co-Author: Ling Zhang – Boehringer Ingelheim
### @@@ Christian Niyonkuru – Boehringer Ingelheim ### 1660102###Co-Author######Boehringer Ingelheim###
Co-Author: Christian Niyonkuru – Boehringer Ingelheim
### @@@ Laurieann Nessralla – Boehringer Ingelheim ### 1991177###Co-Author######Boehringer Ingelheim###
Co-Author: Laurieann Nessralla – Boehringer Ingelheim
### @@@ Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC ### 1088317###Co-Author###Founder and President###CERobs Consulting, LLC###
Co-Author: Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC
###
Risk of Breakthrough SARS-CoV-2 Infection and Clinical Outcomes Among Patients with Type 2 Diabetes

Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Presenting Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ahhyung Choi, PharmD – School of Pharmacy, Sungkyunkwan University ### 1358469###Co-Author###PhD Student###School of Pharmacy, Sungkyunkwan University###
Co-Author: Ahhyung Choi, PharmD – School of Pharmacy, Sungkyunkwan University
### @@@ Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ### 1991599###Co-Author######Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea###
Co-Author: Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
### @@@ Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991609###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###
Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
### @@@ Won Suk Choi, MD, PhD – Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, South Korea ### 1991736###Co-Author######Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, South Korea###
Co-Author: Won Suk Choi, MD, PhD – Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, South Korea
### @@@ Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea ### 1991610###Co-Author######Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea###
Co-Author: Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: a cohort study using the PHARMO Data Network

Karin M.A Swart, PhD – PHARMO Institute for Drug Outcomes Research ### 1358327###Presenting Author###Senior Researcher###PHARMO Institute for Drug Outcomes Research###
Presenting Author: Karin M.A Swart, PhD – PHARMO Institute for Drug Outcomes Research
### @@@ Brenda N. Baak, MSc – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands ### 1991329###Co-Author###Researcher and PhD Student###PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands###
Co-Author: Brenda N. Baak, MSc – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
### @@@ Louise Lemmens – PHARMO Institute for Drug Outcomes Research ### 1358900###Co-Author######PHARMO Institute for Drug Outcomes Research###
Co-Author: Louise Lemmens – PHARMO Institute for Drug Outcomes Research
### @@@ Fernie J. Penning-van Beest – PHARMO Institute for Drug Outcomes Research ### 1358902###Co-Author######PHARMO Institute for Drug Outcomes Research###
Co-Author: Fernie J. Penning-van Beest – PHARMO Institute for Drug Outcomes Research
### @@@ Camilla Bengtsson – IQVIA ### 1991396###Co-Author######IQVIA###
Co-Author: Camilla Bengtsson – IQVIA
### @@@ Muriel Lobier – IQVIA ### 1991397###Co-Author######IQVIA###
Co-Author: Muriel Lobier – IQVIA
### @@@ Fabian Hoti – IQVIA, Global Database Studies - Real World Solutions, Espoo, Finland ### 1657594###Co-Author###Director, Biostatistics###IQVIA, Global Database Studies - Real World Solutions, Espoo, Finland###
Co-Author: Fabian Hoti – IQVIA, Global Database Studies - Real World Solutions, Espoo, Finland
### @@@ Dina Vojinovic – IQVIA ### 1991398###Co-Author######IQVIA###
Co-Author: Dina Vojinovic – IQVIA
### @@@ Lindy van Burk – AstraZeneca ### 1991399###Co-Author######AstraZeneca###
Co-Author: Lindy van Burk – AstraZeneca
### @@@ Kirsty Rhodes – AstraZeneca ### 1657793###Co-Author######AstraZeneca###
Co-Author: Kirsty Rhodes – AstraZeneca
### @@@ Sami Simons – Maastricht University Medical Center ### 1991400###Co-Author######Maastricht University Medical Center###
Co-Author: Sami Simons – Maastricht University Medical Center
### @@@ Clementine Nordon, MD, PhD – AstraZeneca ### 1657794###Co-Author###Director###AstraZeneca###
Co-Author: Clementine Nordon, MD, PhD – AstraZeneca
### @@@ Ron M.C. Herings, PharmD,PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands ### 1657462###Co-Author###Professor in Pharmaco-epidemiology and Healthcare Optimization, Director of the PHARMO Institute###PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands###
Co-Author: Ron M.C. Herings, PharmD,PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
###
Risk of Childhood Leukemia and Lymphoma after In-utero Exposure to Maternal Diabetes and Antidiabetics – a Nordic Population-based Study

Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1358190###Presenting Author###Associate professor###Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###
Presenting Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Laura K Seppälä – Tampere University Hospital, Tampere, Finland ### 1991291###Co-Author######Tampere University Hospital, Tampere, Finland###
Co-Author: Laura K Seppälä – Tampere University Hospital, Tampere, Finland
### @@@ Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1900337###Co-Author###Researcher###PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Marie Hargreave – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark ### 1991292###Co-Author######Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark###
Co-Author: Marie Hargreave – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
### @@@ Caroline H Hemmingsen – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark ### 1991293###Co-Author######Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark###
Co-Author: Caroline H Hemmingsen – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
### @@@ Sarah Hjorth – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1062541###Co-Author######PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Sarah Hjorth – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Susanne K Kjaer – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark ### 1991294###Co-Author######Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark###
Co-Author: Susanne K Kjaer – Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
### @@@ Lina S Mørch – Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark ### 1093592###Co-Author######Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark###
Co-Author: Lina S Mørch – Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark
### @@@ Ulrika Nörby – Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden ### 1991295###Co-Author######Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden###
Co-Author: Ulrika Nörby – Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden
### @@@ Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
###
Risk of Guillain-Barré syndrome following COVID-19 vaccines: a nationwide self-controlled case series study

Stéphane Le Vu – EPI-PHARE (ANSM/CNAM) ### 1655649###Co-Author######EPI-PHARE (ANSM/CNAM)###
Co-Author: Stéphane Le Vu – EPI-PHARE (ANSM/CNAM)
### @@@ Marion Bertrand – EPI-PHARE (ANSM/CNAM) ### 1359610###Co-Author###MSc###EPI-PHARE (ANSM/CNAM)###
Co-Author: Marion Bertrand – EPI-PHARE (ANSM/CNAM)
### @@@ Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE ### 1360499###Presenting Author###PhD, PharmD, MPH###EPI-PHARE###
Presenting Author: Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE
### he/him/his @@@ Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE (ANSM/CNAM) ### 1360145###Co-Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###
Co-Author: Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE (ANSM/CNAM)
### @@@ Jérôme Drouin – EPI-PHARE (ANSM/CNAM) ### 1360500###Co-Author######EPI-PHARE (ANSM/CNAM)###
Co-Author: Jérôme Drouin – EPI-PHARE (ANSM/CNAM)
### @@@ Laura Semenzato – EPI-PHARE (ANSM/CNAM) ### 1360498###Co-Author######EPI-PHARE (ANSM/CNAM)###
Co-Author: Laura Semenzato – EPI-PHARE (ANSM/CNAM)
### @@@ Alain Weill – EPI-PHARE ### 1358499###Co-Author######EPI-PHARE###
Co-Author: Alain Weill – EPI-PHARE
### @@@ Rosemary Dray-Spira – EPI-PHARE ### 1093512###Co-Author######EPI-PHARE###
Co-Author: Rosemary Dray-Spira – EPI-PHARE
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE###
Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE
###
Risk of Opioid Overdose with Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors

Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Presenting Author###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ C. Andrew Basham, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA ### 1991170###Co-Author###Research Fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA###
Co-Author: C. Andrew Basham, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA
### he/him/his @@@ Nazleen F. Khan, PhD – Merck ### 1063044###Co-Author######Merck###
Co-Author: Nazleen F. Khan, PhD – Merck
### @@@ Seanna Vine – Brigham and Women's Hospital ### 1397958###Co-Author######Brigham and Women's Hospital###
Co-Author: Seanna Vine – Brigham and Women's Hospital
### @@@ Heba H. Edrees, PharmD – Brigham and Women's Hospital ### 1359849###Co-Author######Brigham and Women's Hospital###
Co-Author: Heba H. Edrees, PharmD – Brigham and Women's Hospital
### @@@ Julianna Mastrorilli – Brigham and Women’s Hospital ### 1659305###Co-Author######Brigham and Women’s Hospital###
Co-Author: Julianna Mastrorilli – Brigham and Women’s Hospital
### @@@ Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine ### 1088175###Co-Author######Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine###
Co-Author: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###
Risk of Osteoporotic Fractures in Menopausal Women with Common Mental Health Problems Using SSRI/SNRI antidepressants: Cohort Study

Dana Alsugeir, Msc. PharmD. – University college london ### 1657708###Presenting Author###PhD student###University college london###
Presenting Author: Dana Alsugeir, Msc. PharmD. – University college london
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###
Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### @@@ Matthew Adesuyan, MPharm – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom. ### 1657300###Co-Author###PhD Researcher###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.###
Co-Author: Matthew Adesuyan, MPharm – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.
### @@@ Vikram Talaulikar – University college london hospitals ### 1991544###Co-Author######University college london hospitals###
Co-Author: Vikram Talaulikar – University college london hospitals
### @@@ Ruth Brauer, PhD – University College London ### 1062558###Co-Author###Lecturer in Pharmacoepidemiology###University College London###
Co-Author: Ruth Brauer, PhD – University College London
###
Risk of preterm birth associated with ADHD medication use in pregnancy

Chaitra Srinivas, PharmD, MMSc (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health ### 1659381###Co-Author###PhD Candidate###Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health###
Co-Author: Chaitra Srinivas, PharmD, MMSc (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### she/her/hers @@@ Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health ### 1358431###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health###
Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health
### @@@ Hein Stigum – University of Oslo ### 1991298###Co-Author######University of Oslo###
Co-Author: Hein Stigum – University of Oslo
### @@@ Kari Furu, PhD – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health ### 1063219###Co-Author###Senior researcher###Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health###
Co-Author: Kari Furu, PhD – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### @@@ Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1062759###Co-Author###Researcher###Centre for Pharmacoepidemiology, Karolinska Institutet###
Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1358377###Co-Author###Associate professor###Centre for Pharmacoepidemiology, Karolinska Institutet###
Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Jennifer Hutcheon – University of British Columbia ### 1991299###Co-Author######University of British Columbia###
Co-Author: Jennifer Hutcheon – University of British Columbia
### @@@ Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health ### 1360547###Presenting Author###Senior Researcher###Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health###
Presenting Author: Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### she/her/hers
Risk of stroke with various types of menopausal hormone therapy: A Swedish nationwide Register-based Emulated Target trial

Therese Johansson – Department of Immunology, Genetics and Pathology, Uppsala University ### 1991164###Presenting Author###PhD candidate###Department of Immunology, Genetics and Pathology, Uppsala University###
Presenting Author: Therese Johansson – Department of Immunology, Genetics and Pathology, Uppsala University
### @@@ Philip Fowler, PhD – Department of Statistics ### 1991386###Co-Author######Department of Statistics###
Co-Author: Philip Fowler, PhD – Department of Statistics
### @@@ Alkistis Skalkidou – Department of Women's and Children's Health ### 1991387###Co-Author######Department of Women's and Children's Health###
Co-Author: Alkistis Skalkidou – Department of Women's and Children's Health
### @@@ Weronica E. Ek, PhD – Department of immunology, genetics and pathology ### 1991388###Co-Author###Associate Professor###Department of immunology, genetics and pathology###
Co-Author: Weronica E. Ek, PhD – Department of immunology, genetics and pathology
### @@@ Torgny Karlsson – Department of Immunology, Genetics and Pathology, Uppsala University ### 1991166###Co-Author###Researcher###Department of Immunology, Genetics and Pathology, Uppsala University###
Co-Author: Torgny Karlsson – Department of Immunology, Genetics and Pathology, Uppsala University
### @@@ Åsa Johansson, PhD – Department of Immunology, Genetics and Pathology, Uppsala University ### 1991165###Co-Author###Associate professor###Department of Immunology, Genetics and Pathology, Uppsala University###
Co-Author: Åsa Johansson, PhD – Department of Immunology, Genetics and Pathology, Uppsala University
###
Risk of thyroid cancer associated with incretin-based drugs among patients with type 2 diabetes

Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Presenting Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Heejun Son, MD – Division of Endocrinology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea ### 1991600###Co-Author######Division of Endocrinology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea###
Co-Author: Heejun Son, MD – Division of Endocrinology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
### @@@ Jae Hyun Bae, MD, PhD – Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea ### 1991601###Co-Author######Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea###
Co-Author: Jae Hyun Bae, MD, PhD – Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
### @@@ Sun Wook Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991602###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###
Co-Author: Sun Wook Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991609###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###
Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
###
Risky Business...

Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia ### 1358233###Co-Moderator###Senior Research Fellow###National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia###
Co-Moderator: Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
### she/her/hers @@@ Leyla Sahin, MD (she/her/hers) – US Food and Drug Administration ### 1360167###Co-Moderator###Deputy Director for Safety###US Food and Drug Administration###
Co-Moderator: Leyla Sahin, MD (she/her/hers) – US Food and Drug Administration
### she/her/hers